These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10351152)

  • 21. Balancing evidence and public opinion in health technology assessments: the case of leukoreduction.
    Cleemput I; Leys M; Ramaekers D; Bonneux L
    Int J Technol Assess Health Care; 2006; 22(4):403-7. PubMed ID: 16984672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Universal leukodepletion of blood and febrile transfusion reactions.
    Rennie I; Rawlinson PS; Clark P
    Transfus Med; 2001 Apr; 11(2):115. PubMed ID: 11299029
    [No Abstract]   [Full Text] [Related]  

  • 23. UK patient first to contract vCJD via blood transfusion.
    Sibbald B
    CMAJ; 2004 Mar; 170(7):1087. PubMed ID: 15051685
    [No Abstract]   [Full Text] [Related]  

  • 24. Prions and blood transfusion.
    Barbara J
    Transfus Sci; 2000; 22(1-2):49. PubMed ID: 10771380
    [No Abstract]   [Full Text] [Related]  

  • 25. Leukocyte reduction of blood components: public policy and new technology.
    Dzik S; Aubuchon J; Jeffries L; Kleinman S; Manno C; Murphy MF; Popovsky MA; Sayers M; Silberstein LE; Slichter SJ; Vamvakas EC
    Transfus Med Rev; 2000 Jan; 14(1):34-52. PubMed ID: 10669939
    [No Abstract]   [Full Text] [Related]  

  • 26. Selective or universal leucodepletion: the Italian experience.
    Accorsi P; Iacone A
    Transfus Sci; 2000; 22(1-2):65-7. PubMed ID: 10771386
    [No Abstract]   [Full Text] [Related]  

  • 27. ['Variant of Creutzfeldt-Jacob disease and blood transfusion'; report of the Dutch Health Council].
    van Aken WG
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1444-7. PubMed ID: 11503311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Informing a recipient of blood from a donor who developed Creutzfeldt-Jakob disease: the characteristics of information that warrant its disclosure.
    Steinberg D
    J Clin Ethics; 2001; 12(2):134-40. PubMed ID: 11642064
    [No Abstract]   [Full Text] [Related]  

  • 29. Under pressure.
    Siddall R
    Health Serv J; 2003 Aug; 113(5869):12-3. PubMed ID: 12953390
    [No Abstract]   [Full Text] [Related]  

  • 30. Guidelines on the clinical use of leucocyte-depleted blood components. British Committee for Standards in Haematology, Blood Transfusion Task Force.
    Transfus Med; 1998 Mar; 8(1):59-71. PubMed ID: 9569462
    [No Abstract]   [Full Text] [Related]  

  • 31. Universal leucodepletion to reduce potential risk of transmission of new-variant Creutzfeld-Jakob disease.
    Turner M
    Br J Haematol; 2000 Sep; 110(3):745-8. PubMed ID: 10997991
    [No Abstract]   [Full Text] [Related]  

  • 32. [State and perspectives of the French haemovigilance system. Presentation of the data collected over 9 years].
    David B
    Transfus Clin Biol; 2003 Jun; 10(3):131-9. PubMed ID: 12798845
    [No Abstract]   [Full Text] [Related]  

  • 33. Variant Creutzfeldt-Jakob disease (vCJD).
    Wkly Epidemiol Rec; 2001 Dec; 76(50):398-9. PubMed ID: 11797239
    [No Abstract]   [Full Text] [Related]  

  • 34. ISO 9000 in transfusion medicine.
    Dickey WC; Pinover K
    Transfus Med Rev; 1998 Jul; 12(3):188-94. PubMed ID: 9673003
    [No Abstract]   [Full Text] [Related]  

  • 35. Prion safety of transfusion plasma and plasma-derivatives typically used for prophylactic treatment.
    Svae TE; Neisser-Svae A; Bailey A; Reichl H; Biesert L; Schmidt T; Heger A; Römisch J
    Transfus Apher Sci; 2008 Aug; 39(1):59-67. PubMed ID: 18619902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood & politics.
    Titus K
    CAP Today; 1996 Mar; 10(3):20, 22-4. PubMed ID: 10160264
    [No Abstract]   [Full Text] [Related]  

  • 37. The quality of blood starts with its collection.
    Loos JA
    Vox Sang; 1994; 67 Suppl 3():77-9. PubMed ID: 7975516
    [No Abstract]   [Full Text] [Related]  

  • 38. Blood groups differ on donor deferral.
    Mitka M
    JAMA; 2001 Apr; 285(13):1694-5. PubMed ID: 11277807
    [No Abstract]   [Full Text] [Related]  

  • 39. Can CJD be transmitted through the blood supply?
    Giulivi A
    CMAJ; 1998 Mar; 158(6):714; author reply 715-7. PubMed ID: 9538847
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of performance of white blood cell reduction filters: an original flow cytometric method for detection and quantification of cell-derived membrane fragments.
    Hérault O; Binet C; Rico A; Degenne M; Bernard MC; Chassaigne M; Sensebe L
    Cytometry; 2001 Dec; 45(4):277-84. PubMed ID: 11746097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.